激肽原1(KNG1)多克隆抗體
Polyclonal Antibody to Kininogen 1 (KNG1)
BDK; KNG; HMWK; Alpha-2-Thiol Proteinase Inhibitor; Bradykinin; Kallidin; Fitzgerald factor; High molecular weight kininogen; Williams-Fitzgerald-Flaujeac factor; Ile-Ser-Bradykinin
- 編號PAB267Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB267Hu01-激肽原1(KNG1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 濃度1mg/ml
- 且適物種Sus scrofa; Porcine (Pig,豬)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 598 ¥ 1394 ¥ 1992 ¥ 4980 ¥ 19920
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對KNG1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別KNG1。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB267Hu01 | 激肽原1(KNG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB267Hu01 | 激肽原1(KNG1)多克隆抗體 | WB; IHC; ICC; IP. |
MAB267Hu22 | 激肽原1(KNG1)單克隆抗體 | WB; IHC; ICC; IP. |
SEB267Hu | 激肽原1(KNG1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB267Hu | 激肽原1(KNG1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSB267Hu01 | 激肽原1(KNG1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
PLoS One | Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis [PubMed: 26098644] |
Universit?t Leipzig, Dissertation | Einfluss zyklischer mechanischer Dehnung auf das Kinin-Kallikrein-System in alveol?ren Typ-II-Zellen der Ratte [21931] |
Biomedicine & Pharmacotherapy | Evaluation of the anti-hypertensive effect of Tengfu Jiangya tablet by combination of UPLC-Q-exactive-MS-based metabolomics and iTRAQ-based proteomics?… [Pubmed:29453042] |
Clinical and Applied Thrombosis/Hemostasis | Contact System Activation and Neutrophil Extracellular Trap Markers: Risk Factors for Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma [Doi: 10.1177/1076029618825310] |
experimental and clinical endocrinology & diabetes | Activation of Factor XII and Kallikrein-kinin System Combined with Neutrophil Extracellular Trap Formation in Diabetic Retinopathy [Pubmed: 31426112] |
Einfluss mechanischer Dehnung von alveolaren Typ-II-Zellen auf die Bildung von Bradykinin durch das Kallikrein-Kinin-System [] | |
Scientific Reports | Maternal Serum Proteomic Profiles of Pregnant Women With Type 1 Diabetes [34940989] |
留言咨詢